The Long-Term Outcomes after Radical Prostatectomy of Patients with Pathologic Gleason 8–10 Disease

Table 1

Demographics and pathologic and clinical outcomes.

Characteristic	No. (IQR)
Median followup in years	8.2 (4.5–12.5)
Median age in years	65 (61–69)
Median pre-op PSA	9.7 (6.1–13.4)
Pathologic tumor volume	5.3 (3.0–12.0)
Pathologic Gleason sum	No. (%)
Gleason 8	68 (74.7)
Gleason 9	22 (24.2)
Gleason 10	1 (1.1)
Pathologic stage
pT2	28 (31.1)
pT3/4	62 (68.9)
Positive margins	48 (52.7)
Lymph node dissection and node status
Nx	34 (37.4)
N0	49 (53.8)
N1	6 (6.6)
N2	2 (2.2)
Adjuvant radiation	10 (11.0)
Salvage radiation	10 (11.0)
Neoadjuvant ADT	9 (9.9)
Salvage ADT	19 (20.9)
Biochemical recurrence	33 (36.3)
Metastatic disease	8(8.8)
PCSM	9 (9.9)
Total no. patients	91 (100)

ADT: androgen deprivation therapy.